The criticism additional alleges that J&J and Janssen had been informed that Risperdal posed really serious health dangers to the aged, which include an elevated risk of strokes, but that the companies downplayed these challenges. One example is, every time a J&J examine of Risperdal showed a major threat of strokes as well as other adverse events